← Open Payments lookup

ROBERT LAITMAN: Open Payments

NPI 1427046689 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 45 payments from 7 companies in 2025. Trend: 2023 $355 · 2024 $356 · 2025 $1,209

Food & beverage: $1,209
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$507
E.R. Squibb & Sons, L.L.C.16$399
Teva Pharmaceuticals USA, Inc.7$185
Lilly USA, LLC2$52
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Novo Nordisk Inc1$22
Otsuka America Pharmaceutical, Inc.1$21

Products named: INGREZZA, COBENFY, AUSTEDO XR, MOUNJARO, JARDIANCE, REXULTI.

Industry payments across NY — which companies pay providers there.